REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 180 filers reported holding REGENXBIO INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $292,412 | -2.1% | 17,765 | +18.9% | 0.00% | – |
| Q2 2023 | $298,610 | -44.4% | 14,938 | -47.4% | 0.00% | – |
| Q1 2023 | $537,460 | -19.6% | 28,422 | -3.6% | 0.00% | – |
| Q4 2022 | $668,652 | +1.6% | 29,482 | +18.3% | 0.00% | – |
| Q3 2022 | $658,000 | -2.5% | 24,928 | -8.7% | 0.00% | – |
| Q2 2022 | $675,000 | -37.0% | 27,291 | -15.5% | 0.00% | – |
| Q1 2022 | $1,071,000 | +2.8% | 32,278 | +1.4% | 0.00% | – |
| Q4 2021 | $1,042,000 | -62.6% | 31,831 | -52.1% | 0.00% | -100.0% |
| Q3 2021 | $2,784,000 | +6.9% | 66,396 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $2,605,000 | +6.8% | 67,074 | -6.3% | 0.00% | 0.0% |
| Q1 2021 | $2,440,000 | -15.9% | 71,555 | +11.9% | 0.00% | -50.0% |
| Q4 2020 | $2,901,000 | +86.9% | 63,927 | +13.3% | 0.00% | +100.0% |
| Q3 2020 | $1,552,000 | -56.2% | 56,400 | -41.4% | 0.00% | -66.7% |
| Q2 2020 | $3,544,000 | +36.6% | 96,255 | +20.1% | 0.00% | +50.0% |
| Q1 2020 | $2,595,000 | -33.5% | 80,170 | -15.9% | 0.00% | -33.3% |
| Q4 2019 | $3,903,000 | +133.9% | 95,329 | +103.1% | 0.00% | +200.0% |
| Q3 2019 | $1,669,000 | -32.8% | 46,942 | -3.0% | 0.00% | 0.0% |
| Q2 2019 | $2,483,000 | -85.7% | 48,369 | -84.0% | 0.00% | -90.0% |
| Q1 2019 | $17,335,000 | -3.7% | 302,526 | -29.5% | 0.01% | -23.1% |
| Q4 2018 | $18,010,000 | -61.8% | 429,371 | -31.3% | 0.01% | -7.1% |
| Q3 2018 | $47,151,000 | +53.4% | 624,544 | +45.7% | 0.01% | +55.6% |
| Q2 2018 | $30,746,000 | +199.7% | 428,543 | +24.7% | 0.01% | +80.0% |
| Q1 2018 | $10,259,000 | +70.0% | 343,753 | +89.2% | 0.01% | +25.0% |
| Q4 2017 | $6,036,000 | -5.5% | 181,640 | -6.4% | 0.00% | 0.0% |
| Q3 2017 | $6,389,000 | +79.1% | 193,975 | +7.3% | 0.00% | +33.3% |
| Q2 2017 | $3,567,000 | +67.9% | 180,709 | +63.8% | 0.00% | +50.0% |
| Q1 2017 | $2,125,000 | +82.1% | 110,306 | +75.0% | 0.00% | +100.0% |
| Q4 2016 | $1,167,000 | +114.5% | 63,028 | +61.7% | 0.00% | – |
| Q3 2016 | $544,000 | +121.1% | 38,967 | +26.1% | 0.00% | – |
| Q2 2016 | $246,000 | -20.9% | 30,897 | +7.0% | 0.00% | – |
| Q1 2016 | $311,000 | -36.5% | 28,880 | -2.4% | 0.00% | – |
| Q4 2015 | $490,000 | -19.8% | 29,600 | +6.6% | 0.00% | – |
| Q3 2015 | $611,000 | – | 27,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |